Remove FDA Remove Governance Remove Licensing Remove Presentation
article thumbnail

Microdosing at Work: Business and Legal Implications

Bill of Health

The Food and Drug Administration has authorized studies of psychedelics , including on a “breakthrough therapy” designation, but these drugs may not be handled by persons without a Drug Enforcement Administration license and outside an FDA approved setting. They may do well to follow suit with respect to psychedelics.

Licensing 293
article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. government. government substantially de-risking the vaccine development process.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital Health in the Metaverse: Three Legal Considerations

Healthcare Law Blog

These advancements, present challenges and raise novel questions as to how the current healthcare and life sciences legal regime would apply to the metaverse. In response to the growth of the metaverse and digital health generally, the FDA has been working to expand its guidance in the area. Data Privacy and Security. Healthcare Laws.

FDA 90
article thumbnail

Key Legal Issues Facing Telehealth Platforms, as Compliance Concerns Bubble for Platforms Launched During the Public Health Emergency

Health Care Law Brief

Therefore, a telehealth platform operating in all 50 states will, for example, need to comport with the laws governing corporate formation, provider licensure, scope of practice, and telehealth encounters in all 50 states. Variety of Risks Present in Telehealth Arrangements. Provider Licenses.

article thumbnail

How Should RPM Vendors Choose Remote Patient Monitoring Device Suppliers?

Healthcare IT Today

They purchase the technical solutions such as algorithms and software licenses with no R&D or engineering capabilities on staff. RPM devices work as medical devices which are governed by the FDA and related departments. Principle 2: Evaluate the regulation competence of the suppliers. There were not any outside connections.

FDA 89
article thumbnail

SQA Regulatory Surveillance Summary 4 | Monthly Update 2021

SQA

ANVISA released on 05 March the report Regulation in Numbers , presenting the 2020 actions aiming to improve the regulatory quality of the Agency. Backgrounder – Government of Canada Investments in Biomanufacturing, Development of COVID-19 Vaccines and Therapeutics, and Research, 18 May 2021. Health Canada – Biologics.

FDA 52
article thumbnail

Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA

Bill of Health

In the July 29, 2022 notice, the USPTO set forth its views on the “duty of disclosure” and “duty of reasonable inquiry,” emphasizing the importance of consistency between statements made to the USPTO, the FDA, and other governmental agencies. Background Context.

FDA 130